Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Renal Cell Carcinoma × balstilimab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Colorectal Neoplasms 11 Pancreatic Neoplasms 6 Uterine Cervical Neoplasms 5 Stomach Neoplasms 3 Rectal Neoplasms 3 Prostatic Neoplasms 3 Neoplasm Metastasis 3 Carcinoma, Non-Small-Cell Lung 3 Sarcoma 2 Ovarian Neoplasms 2 Neoplasms 2 Melanoma 2 Hemangiosarcoma 2 Colonic Neoplasms 2 Urinary Bladder Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Resectable MMR-deficient Solid Tumors 1 Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC) 1 Pancreatic Cancer Metastatic 1 Oropharyngeal Neoplasms 1 Microsatellite Stable Rectal Carcinoma 1 Lymphoma 1 Glioma 1 Fibrolamellar hepatocellular carcinoma 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Diffuse Intrinsic Pontine Glioma 1 Diabetes Mellitus, Insulin-Dependent, 12 1 Colorectal Cancer Metastatic 1 Carcinoma, Hepatocellular 1

Interventions

balstilimab 1 Nivolumab 1 Ipilimumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05928806 2026-02-11

ARCITECT

Hoosier Cancer Research Network

Phase 2 Suspended

Advanced Renal Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡